Literature DB >> 26506890

Using pilot data to size a two-arm randomized trial to find a nearly optimal personalized treatment strategy.

Eric B Laber1, Ying-Qi Zhao1, Todd Regh1, Marie Davidian1, Anastasios Tsiatis1, Joseph B Stanford1, Donglin Zeng1, Rui Song1, Michael R Kosorok1.   

Abstract

A personalized treatment strategy formalizes evidence-based treatment selection by mapping patient information to a recommended treatment. Personalized treatment strategies can produce better patient outcomes while reducing cost and treatment burden. Thus, among clinical and intervention scientists, there is a growing interest in conducting randomized clinical trials when one of the primary aims is estimation of a personalized treatment strategy. However, at present, there are no appropriate sample size formulae to assist in the design of such a trial. Furthermore, because the sampling distribution of the estimated outcome under an estimated optimal treatment strategy can be highly sensitive to small perturbations in the underlying generative model, sample size calculations based on standard (uncorrected) asymptotic approximations or computer simulations may not be reliable. We offer a simple and robust method for powering a single stage, two-armed randomized clinical trial when the primary aim is estimating the optimal single stage personalized treatment strategy. The proposed method is based on inverting a plugin projection confidence interval and is thereby regular and robust to small perturbations of the underlying generative model. The proposed method requires elicitation of two clinically meaningful parameters from clinical scientists and uses data from a small pilot study to estimate nuisance parameters, which are not easily elicited. The method performs well in simulated experiments and is illustrated using data from a pilot study of time to conception and fertility awareness.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  nonregular asymptotics; personalized medicine; projection confidence region; sample size calculation; treatment regimes

Mesh:

Year:  2015        PMID: 26506890      PMCID: PMC4777666          DOI: 10.1002/sim.6783

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  28 in total

1.  Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part I: main content.

Authors:  Liliana Orellana; Andrea Rotnitzky; James M Robins
Journal:  Int J Biostat       Date:  2010       Impact factor: 0.968

2.  The path to personalized medicine.

Authors:  Margaret A Hamburg; Francis S Collins
Journal:  N Engl J Med       Date:  2010-06-15       Impact factor: 91.245

3.  An experimental design for the development of adaptive treatment strategies.

Authors:  S A Murphy
Journal:  Stat Med       Date:  2005-05-30       Impact factor: 2.373

4.  A Generalization Error for Q-Learning.

Authors:  Susan A Murphy
Journal:  J Mach Learn Res       Date:  2005-07       Impact factor: 3.654

Review 5.  Sample size planning for statistical power and accuracy in parameter estimation.

Authors:  Scott E Maxwell; Ken Kelley; Joseph R Rausch
Journal:  Annu Rev Psychol       Date:  2008       Impact factor: 24.137

6.  Estimation and extrapolation of optimal treatment and testing strategies.

Authors:  James Robins; Liliana Orellana; Andrea Rotnitzky
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

7.  Obtaining power or obtaining precision. Delineating methods of sample-size planning.

Authors:  Ken Kelley; Scott E Maxwell; Joseph R Rausch
Journal:  Eval Health Prof       Date:  2003-09       Impact factor: 2.651

8.  Adaptive Confidence Intervals for the Test Error in Classification.

Authors:  Eric B Laber; Susan A Murphy
Journal:  J Am Stat Assoc       Date:  2011-09-01       Impact factor: 5.033

9.  PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

Authors:  Min Qian; Susan A Murphy
Journal:  Ann Stat       Date:  2011-04-01       Impact factor: 4.028

Review 10.  Inference for non-regular parameters in optimal dynamic treatment regimes.

Authors:  Bibhas Chakraborty; Susan Murphy; Victor Strecher
Journal:  Stat Methods Med Res       Date:  2009-07-16       Impact factor: 3.021

View more
  7 in total

1.  Power analysis in a SMART design: sample size estimation for determining the best embedded dynamic treatment regime.

Authors:  William J Artman; Inbal Nahum-Shani; Tianshuang Wu; James R Mckay; Ashkan Ertefaie
Journal:  Biostatistics       Date:  2020-07-01       Impact factor: 5.899

2.  Active Clinical Trials for Personalized Medicine.

Authors:  Stanislav Minsker; Ying-Qi Zhao; Guang Cheng
Journal:  J Am Stat Assoc       Date:  2016-08-18       Impact factor: 5.033

3.  Precision Medicine.

Authors:  Michael R Kosorok; Eric B Laber
Journal:  Annu Rev Stat Appl       Date:  2019-03       Impact factor: 5.810

4.  A SMART data analysis method for constructing adaptive treatment strategies for substance use disorders.

Authors:  Inbal Nahum-Shani; Ashkan Ertefaie; Xi Lucy Lu; Kevin G Lynch; James R McKay; David W Oslin; Daniel Almirall
Journal:  Addiction       Date:  2017-02-18       Impact factor: 6.526

5.  Design of the Advancing Care for Type 1 Diabetes and Obesity Network energy metabolism and sequential multiple assignment randomized trial nutrition pilot studies: An integrated approach to develop weight management solutions for individuals with type 1 diabetes.

Authors:  Karen D Corbin; Daria Igudesman; Ananta Addala; Anna Casu; Jamie Crandell; Michael R Kosorok; David M Maahs; Teeranan Pokaprakarn; Richard E Pratley; Katherine J Souris; Joan M Thomas; Dessi P Zaharieva; Elizabeth J Mayer-Davis
Journal:  Contemp Clin Trials       Date:  2022-04-20       Impact factor: 2.261

6.  Noninferiority and equivalence tests in sequential, multiple assignment, randomized trials (SMARTs).

Authors:  Palash Ghosh; Inbal Nahum-Shani; Bonnie Spring; Bibhas Chakraborty
Journal:  Psychol Methods       Date:  2019-09-09

7.  Constructing dynamic treatment regimes with shared parameters for censored data.

Authors:  Ying-Qi Zhao; Ruoqing Zhu; Guanhua Chen; Yingye Zheng
Journal:  Stat Med       Date:  2020-01-17       Impact factor: 2.373

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.